Founded in 2016, Taurx Therapeutics Europe, classified under reg no. SC531194 is an active company. Currently registered at 395 King Street AB24 5RP, Aberdeen the company has been in the business for eight years. Its financial year was closed on Sunday 30th June and its latest financial statement was filed on 30th June 2022.
The firm has one director. Claude W., appointed on 31 March 2016. There are currently no secretaries appointed. As of 27 April 2024, there was 1 ex director - Timothy E.. There were no ex secretaries.
Office Address | 395 King Street |
Town | Aberdeen |
Post code | AB24 5RP |
Country of origin | United Kingdom |
Registration Number | SC531194 |
Date of Incorporation | Thu, 31st Mar 2016 |
Industry | Research and experimental development on biotechnology |
End of financial Year | 30th June |
Company age | 8 years old |
Account next due date | Sun, 31st Mar 2024 (27 days after) |
Account last made up date | Thu, 30th Jun 2022 |
Next confirmation statement due date | Sat, 13th Apr 2024 (2024-04-13) |
Last confirmation statement dated | Thu, 30th Mar 2023 |
The register of PSCs that own or control the company is made up of 1 name. As we established, there is Taurx Therapeutics Management Ltd. from Aberdeen, United Kingdom. This PSC is categorised as "a private limited company", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares.
Taurx Therapeutics Management Ltd.
395 King Street, Aberdeen, AB24 5RP, United Kingdom
Legal authority | Scots |
Legal form | Private Limited Company |
Country registered | Scotland, Uk |
Place registered | Register For Scotland |
Registration number | Sc531195 |
Notified on | 6 April 2016 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Profit & Loss | |||||||
---|---|---|---|---|---|---|---|
Accounts Information Date | 2017-06-30 | 2018-06-30 | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
Net Worth | 200 | ||||||
Balance Sheet | |||||||
Current Assets | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
Net Assets Liabilities | 200 | 37 | 24 | 8 897 | 8 897 | 10 582 | 12 579 |
Cash Bank In Hand | 200 | ||||||
Net Assets Liabilities Including Pension Asset Liability | 200 | ||||||
Reserves/Capital | |||||||
Shareholder Funds | 200 | ||||||
Other | |||||||
Creditors | 163 | 176 | 9 097 | 8 579 | 10 782 | 12 779 | |
Net Current Assets Liabilities | 200 | 37 | 24 | 8 897 | 8 379 | 10 582 | 12 579 |
Total Assets Less Current Liabilities | 200 | 37 | 24 | 8 897 | 8 897 | 10 582 | 12 579 |
Number Shares Allotted | 200 | ||||||
Par Value Share | 1 | ||||||
Share Capital Allotted Called Up Paid | 200 |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with no updates 30th March 2024 filed on: 12th, April 2024 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy